CJ Bioscience, Inc. engages in the research and development of pharmaceutical products. Its product pipeline includes CJRB-101, CJRB-201, and CJRB-203. The company was founded by Jong-Sik Chun on November 18, 2009 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company